Stock VIRX VIRACTA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Viracta Therapeutics, Inc.

Equities

VIRX

US92765F1084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.8196 USD -0.17% Intraday chart for Viracta Therapeutics, Inc. -3.33% +43.79%
Apr. 15 Viracta Therapeutics, Inc. Reports Positive Topline Results from Stage 1 of the Pivotal Phase 2 NAVAL-1 Trial CI
Apr. 01 Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. VIRX Stock
  4. Revisions Viracta Therapeutics, Inc.